Identifying therapeutic targets for blocking infection of highly pathogenic SARS-CoV-2 at an early stage- Developing novel screening assay with minimal bio-hazard risk
Implementing Organization
Principal Investigator
Dr. A. Krishnan Assistant Professor Jamia Hamdard Delhi